Been invested here 10 years. Fortunately a good result out of SIRTEX Medical but does not compensate for the embarassing red number on a spreadsheet here.
OSL been on shareholder funded life support forever. Sales remain insipid & potential remains questionable @0.7c
Concede that CEO & Management are not idle & step progress is being made. 2025 could see us at .09+ but sheer number of shares on issue with light sales are a big hurdle. GLTAH
Ann: First Patient in Australia Randomised in TRIPP-FFX Trial, page-11
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.79M | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | 99.5¢ | 97.0¢ | $5.782K | 5.896K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4399 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 3684 | 2 |
View Market Depth
| Last trade - 10.57am 24/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |